Uterine leiomyomas occur in approximately 77% of all women in the United States and can cause severe morbidity and infertility, particularly in Black women. In this proposal, we will study the importance of reactive oxygen species (ROS) on initiating leiomyoma tumor development as well as studying how sex hormones, estrogen and progesterone allow the growth of leiomyoma tumors despite the toxic effects of ROS. With this knowledge, we can specifically target this pathway with existing drugs that will clear leiomyoma cells that are under ROS stress.
|Effective start/end date
|8/6/20 → 5/31/26
- National Cancer Institute (5R01CA254367-03)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.